Screening and Treatment of SAHS in Patients With Acute Ischemic Stroke
SAHS
Screening and Treatment of in Sleep Apnea Hypopnea Syndrome(SAHS)Patients With Acute Ischemic Stroke
1 other identifier
interventional
120
1 country
1
Brief Summary
Ischemic stroke is a kind of common disease with great harm. In acute stage of stroke there is sharply increasing morbidity of sleep apnea hypopnea syndrome. Our suppose that treatment with noninvasive ventilation for patients with acute ischemic stroke should improve the functional prognosis(measuring with 90d modified Rankin score).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2013
CompletedStudy Start
First participant enrolled
December 1, 2013
CompletedFirst Posted
Study publicly available on registry
January 7, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedJanuary 7, 2014
January 1, 2014
3 years
November 17, 2013
January 6, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Modified Rankin Scale score
0-2 Modified Rankin Scale score should be recognized good functional prognosis
90 days after symptoms
Study Arms (1)
bi-level positive airway pressure
EXPERIMENTALbi-level positive airway pressure for 6 hour per night,total 7 days
Interventions
Bi level positive pressure ventilation should be given for subject for 6 hours per night ,total 7 times.
Eligibility Criteria
You may qualify if:
- ischeic stroke onset within 48 hours , NIHSS:4-15
You may not qualify if:
- mRs\>2 before onset of enrollment severe hepatic renal insufficiency cancer in reached an advanced stage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking university third hospital
Beijing, Beijing Municipality, 100191, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dongsheng Fan, P
Peking University Third Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 17, 2013
First Posted
January 7, 2014
Study Start
December 1, 2013
Primary Completion
December 1, 2016
Study Completion
May 1, 2017
Last Updated
January 7, 2014
Record last verified: 2014-01